Actinium Pharmaceuticals

+$0.08 (+1.14%) Today
+$0.09 (+1.27%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell ATNM and other stocks, options, and ETFs commission-free!

About ATNM

Actinium Pharmaceuticals, Inc, also called Actinium Pharmaceuticals, is a clinical-stage biopharmaceutical company. It engages in the development of novel targeted therapies known as Antibody Radiation-Conjugates (ARCs), which combine the targeting ability of antibodies with the cell killing ability of radiation.

CEO
Sandesh Seth
Employees
32
Headquarters
New York, New York
Founded
2000

ATNM Key Statistics

Market Cap
136.65M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
135.61K
High Today
$7.24
Low Today
$7.02
Open Price
$7.07
Volume
115.76K
52 Week High
$19.47
52 Week Low
$5.22

ATNM Earnings

-$0.37
-$0.25
-$0.12
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Jun 29, After Hours

You May Also Like

PK
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure